These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 18355786)

  • 1. Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin.
    Hayes EJ; Weinstein L
    Am J Obstet Gynecol; 2008 Jun; 198(6):622.e1-7. PubMed ID: 18355786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin.
    Welch RA
    Am J Obstet Gynecol; 2009 Apr; 200(4):e16; author reply e16. PubMed ID: 19070829
    [No Abstract]   [Full Text] [Related]  

  • 3. Discussion of improving patient safety and uniformity of care by a standard regimen for the use of oxytocin.
    Sandmire HF; De Mott RK
    Am J Obstet Gynecol; 2009 Mar; 200(3):e10; author reply e10. PubMed ID: 19070832
    [No Abstract]   [Full Text] [Related]  

  • 4. High- versus low-dose oxytocin for augmentation or induction of labor.
    Patka JH; Lodolce AE; Johnston AK
    Ann Pharmacother; 2005 Jan; 39(1):95-101. PubMed ID: 15572602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes.
    Clark S; Belfort M; Saade G; Hankins G; Miller D; Frye D; Meyers J
    Am J Obstet Gynecol; 2007 Nov; 197(5):480.e1-5. PubMed ID: 17980181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized comparison of 15- and 40-minute dosing protocols for labor augmentation and induction.
    Lazor LZ; Philipson EH; Ingardia CJ; Kobetitsch ES; Curry SL
    Obstet Gynecol; 1993 Dec; 82(6):1009-12. PubMed ID: 8233251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin augmentation of labor and perinatal outcome in nulliparas.
    Akoury HA; MacDonald FJ; Brodie G; Caddick R; Chaudhry NM; Frize M
    Obstet Gynecol; 1991 Aug; 78(2):227-30. PubMed ID: 2067766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.
    Ozkan S; Calişkan E; Doğer E; Yücesoy I; Ozeren S; Vural B
    Arch Gynecol Obstet; 2009 Jul; 280(1):19-24. PubMed ID: 19034471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation of oxytocin in the active phase of labor.
    Girard B; Vardon D; Creveuil C; Herlicoviez M; Dreyfus M
    Acta Obstet Gynecol Scand; 2009; 88(2):172-7. PubMed ID: 19169930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxytocin as a high-alert medication: implications for perinatal patient safety.
    Simpson KR; Knox GE
    MCN Am J Matern Child Nurs; 2009; 34(1):8-15; quiz 16-7. PubMed ID: 19104313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical appraisal of currently used oxytocin regimen and prospects.
    Berhan Y; Dwivedi AD
    Ethiop Med J; 2007 Jul; 45(3):225-34. PubMed ID: 18330322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin, excessive uterine activity, and patient safety: time for a collaborative approach.
    Miller LA
    J Perinat Neonatal Nurs; 2009; 23(1):52-8. PubMed ID: 19209060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin administration: the transition to a safer model of care.
    Krening CF; Rehling-Anthony K; Garko C
    J Perinat Neonatal Nurs; 2012; 26(1):15-24. PubMed ID: 22293638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labour induction with an intermediate-dose oxytocin regimen has advantages over a high-dose regimen.
    Manjula BG; Bagga R; Kalra J; Dutta S
    J Obstet Gynaecol; 2015 May; 35(4):362-7. PubMed ID: 25384080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of preinduction cervical ripening: misoprostol vs oxytocin.
    Fonseca L; Wood HC; Lucas MJ; Ramin SM; Phatak D; Gilstrap LC; Yeomans ER
    Am J Obstet Gynecol; 2008 Sep; 199(3):305.e1-5. PubMed ID: 18771993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Currently used oxytocin regimen outcome measures at term & postterm. II: Outcome indicators in relation to Bishop Score & other covariates.
    Berhan Y; Dwivedi AD
    Ethiop Med J; 2007 Jul; 45(3):243-50. PubMed ID: 18330324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome in obstetric care related to oxytocin use. A population-based study.
    Oscarsson ME; Amer-Wåhlin I; Rydhstroem H; Källén K
    Acta Obstet Gynecol Scand; 2006; 85(9):1094-8. PubMed ID: 16929414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between the effect of oxytocin only and oxytocin plus propranolol on the labor (a double blind randomized trial).
    Kashanian M; Fekrat M; Zarrin Z; Ansari NS
    J Obstet Gynaecol Res; 2008 Jun; 34(3):354-8. PubMed ID: 18588611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Start of induction of labour with oxytocin in the morning or in the evening. A randomised controlled trial.
    Bakker JJ; De Vos R; Pel M; Wisman C; Van Lith JM; Mol BW; Van Der Post JA
    BJOG; 2009 Mar; 116(4):562-8. PubMed ID: 19250367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin for the induction of labor.
    Blakemore KJ; Petrie RH
    Obstet Gynecol Clin North Am; 1988 Jun; 15(2):339-53. PubMed ID: 3226666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.